SCHEMBL752935

SCHEMBL752935

O=S(=O)(c1ccc(Cl)cc1)C(Br)Br

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
CYP3A4 P08684 1/20 0.54
MAPK1 P28482 1/20 0.54
CA2 P00918 5/20 0.50
CA1 P00915 4/20 0.50
CA12 O43570 4/20 0.50
CA9 Q16790 4/20 0.50
CA14 Q9ULX7 4/20 0.50
CA3 P07451 3/20 0.50
CA4 P22748 3/20 0.50
CA6 P23280 3/20 0.50
CA5A P35218 3/20 0.50
CA7 P43166 3/20 0.50
CA13 Q8N1Q1 3/20 0.50
CA5B Q9Y2D0 3/20 0.50
MMP2 P08253 4/20 0.45
MMP9 P14780 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
MMP1 P03956 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL217302 0.76 ALDH1A1 (0.54) ALDH1A1CYP3A4MAPK1CA2CA1
SCHEMBL5200207 0.76 ALDH1A1 (0.54) ALDH1A1CYP3A4MAPK1CA2CA1
SCHEMBL536323 0.76 ALDH1A1 (0.54) ALDH1A1CYP3A4MAPK1CA2CA1
SCHEMBL751183 0.76 GAA (0.54) ALDH1A1CYP3A4CA2CA1CA12
SCHEMBL9849677 0.75 HTR6 (0.50) ALDH1A1CA2CA1CA12CA9
SCHEMBL8745502 0.74 ALDH1A1 (0.52) ALDH1A1CYP3A4MAPK1CA2CA1
SCHEMBL21515839 0.73 CA1 (0.52) ALDH1A1CYP3A4MAPK1CA2CA1
SCHEMBL6543473 0.73 ALDH1A1 (0.50) ALDH1A1CYP3A4MAPK1CA2CA1
SCHEMBL6544686 0.73 TDP1 (0.50) ALDH1A1CYP3A4MAPK1CA2CA1
SCHEMBL4315677 0.72 ALDH1A1 (0.62) ALDH1A1CYP3A4MAPK1CA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2213166-B1 Biocidal compounds containing 2-methylisothiazolin-3-one and a haloalkylsulfone THOR GMBH (DE) 2012-03-21 EP claimed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US claimed
US-8287631-B2 Compounds for preventing ghost odour THOR GMBH (DE) 2012-10-16 US disclosed
US-20100186631-A1 Compounds for preventing ghost odour THOR GMBH (DE) 2010-07-29 US disclosed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone MBTD1, MPST, B2M ALDH1A1 553/4885CYP3A4 1279/4885MAPK1 3917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.